Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
69,157.23
(
0.39%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

imnot6

Send PM Follow Ignore
Followers 3
Posts 861
Boards Moderated 0
Alias Born 11/28/2005

imnot6

Member Level

Re: jbog post# 44286

Wednesday, 04/04/2007 9:56:20 AM

Wednesday, April 04, 2007 9:56:20 AM

Post# of 257268
"The toxicity profile seen with panitumumab was similar to that seen with Erbitux, [the FDA's] Hughes said...


...., noting that "the apparent lower incidence of infusion-related reactions may relate to how data were collected in the two applications."

Ouch!

(no pun intended)
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today